Buscar resultados de ensayos clínicos
Peripheral Nervous System Neoplasms - 25 Studies Found
Estado | Estudiar |
Not yet recruiting |
Nombre del estudio: Study of CPI-0610 in Patients With Malignant Peripheral Nerve Sheath Tumors Condición: Peripheral Nerve Tumors Fecha: 2016-11-21 Intervenciones: Drug: CPI-0610
|
Recruiting |
Nombre del estudio: Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors Condición: Malignant Peripheral Nerve Sheath Tumors Fecha: 2017-04-13 |
Active, not recruiting |
Nombre del estudio: Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1 Condición:
Fecha: 2017-03-08 Intervenciones:
|
Recruiting |
Nombre del estudio: Photodynamic Therapy for Benign Dermal Neurofibromas Condición: NEUROFIBROMATOSIS 1 Fecha: 2016-03-25 Intervenciones: Procedure: PDT Treatment Drug: Levulan Kerastick |
Recruiting |
Nombre del estudio: A Study of Pembrolizumab in Patients With Malignant Peripheral Nerve Sheath Tumor (MPNST), Not Eligible for Curative Surgery Condición: Malignant Peripheral Nerve Sheath Tumour (MPNST) Fecha: 2016-02-04 Intervenciones: Drug: Pembrolizumab Other Name: Keytruda |
Recruiting |
Nombre del estudio: Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (PNs) Condición:
Fecha: 2015-09-05 |
Recruiting |
Nombre del estudio: Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas Condición: Plexiform Neurofibromas Fecha: 2014-06-25 Intervenciones: Drug: Imatinib Mesylate oral administration Other Na |
Recruiting |
Nombre del estudio: Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations Condición: Cancer Fecha: 2014-04-24 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 (16 Years +) Condición:
Fecha: 2014-03-14 Intervenciones: Drug: Cabozantinib Open label Phase II clinical trials. All subjects will start cabozantinib at 40 mg. S |
Active, not recruiting |
Nombre del estudio: PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1) Condición:
|